Apellis Pharmaceuticals, Inc. (BIT:1APLS)
Italy flag Italy · Delayed Price · Currency is EUR
17.62
-0.18 (-1.01%)
Last updated: Mar 12, 2026, 9:41 AM CET

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EMPAVELI Revenue
102.45M98.09M
EMPAVELI Revenue Growth
4.44%7.75%
SYFOVRE Revenue
586.93M611.86M
SYFOVRE Revenue Growth
-4.07%122.30%
Total Product Revenue
689.38M709.95M
Total Product Revenue Growth
-2.90%93.83%
Licensing and Other Revenue
314.40M71.41M
Licensing and Other Revenue Growth
340.25%135.61%
Revenue (Total)
1.00B781.37M
Revenue (Total) Growth
28.46%97.02%
Updated Dec 31, 2025. Data Source: Fiscal.ai.